Urological Oncology Department I

The Department of Urology of the First Affiliated Hospital of Dalian Medical University is a first-level key discipline in Dalian and a Dalian Urological Tumor Diagnosis and Treatment Base. The department is equipped with advanced diagnostic and treatment facilities, including cystoscopes, ureteroscopes, percutaneous nephroscopes, laparoscopes, holmium lasers, and ion-beam equipment, as well as departments and centers including a urodynamic testing center, lithotripsy center, andrology examination and treatment center, Specialist Physician Training Base of the Urology Branch of the Chinese Medical Association, National Drug Experimental Base, and Specialist Physician Training Base. The department currently has 10 physicians, 1 technician, and 20 nurses. Among the physicians, there are 3 professors, 4 associate professors, and 3 attending physicians. Eight have postgraduate education, including 5 with doctoral degrees and 3 with master’s degrees. Approximately 90% of the physicians have studied or received advanced training at renowned medical centers in China and abroad. Three serve as deputy directors, standing committee members, or members of national- or provincial-level professional societies; 1 serves as an editorial board member of national- and provincial-level professional journals; and 1 has received the State Council’s Special Government Allowance. In 1994, the department became a master’s degree training base of the university, and in 2006, it was approved as a doctoral degree-granting site. The department currently has 3 master’s supervisors and 1 doctoral supervisor, and has trained more than 70 master’s and doctoral students.

The clinical subspecialties are comprehensive, including benign prostatic hyperplasia, urological tumors, endourology, urinary continence, urinary calculi, and andrology. The department has successively introduced new technologies, including holmium laser treatment for bladder tumors, urinary calculi, and scrotal Paget’s disease; nephron-sparing surgery for renal tumors; laparoscopic treatment of adrenal tumors, renal tumors, prostate cancer, and other urological diseases; total pelvic exenteration for advanced bladder cancer; percutaneous nephrolithotomy for renal calculi; and radical cystectomy with orthotopic continent ileal neobladder reconstruction, bringing significant benefits to patients.

As a leading department in Liaoning Province, over the past three years it has averaged more than 3,000 inpatient visits per year and more than 60,000 outpatient visits per year. The department is at the leading level nationally and within the province in the fields of urological tumors, endourology, urinary calculi, urinary continence, and andrology. It has established extensive collaborations with renowned international centers, including Ehime University in Japan, Tokyo Medical University, the University of Melbourne in Australia, the Brady Urological Institute at Johns Hopkins in the United States, and the University of Oslo in Norway, with which it has successively established long-term friendly cooperative relationships.

In recent years, the department has completed and is currently conducting 5 national-level scientific research projects and more than 10 provincial- and ministerial-level projects, with total funding of nearly RMB 3 million. It has received 2 second prizes and 4 third prizes for scientific and technological progress at the provincial level, and 2 first prizes and 4 second prizes for scientific and technological progress in Dalian. It has published 17 papers indexed by SCI, more than 80 papers in Chinese core journals, and has participated in compiling 5 textbooks and monographs.